150 related articles for article (PubMed ID: 32390297)
1. Factors Impacting Differential Outcomes in the Definitive Radiation Treatment of Anal Cancer Between HIV-Positive and HIV-Negative Patients.
Susko M; Wang CJ; Lazar AA; Kim S; Laffan A; Feng M; Ko A; Venook AP; Atreya CE; Van Loon K; Anwar M
Oncologist; 2020 Sep; 25(9):772-779. PubMed ID: 32390297
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Toxicity and Treatment Outcomes in HIV-positive Versus HIV-negative Patients With Squamous Cell Carcinoma of the Anal Canal.
White EC; Khodayari B; Erickson KT; Lien WW; Hwang-Graziano J; Rao AR
Am J Clin Oncol; 2017 Aug; 40(4):386-392. PubMed ID: 25513996
[TBL] [Abstract][Full Text] [Related]
3. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
[TBL] [Abstract][Full Text] [Related]
4. Disease-Free Survival and Time to Complete Response After Definitive Chemoradiotherapy for Squamous-Cell Carcinoma of the Anus According to HIV Infection.
Camandaroba MPG; Iseas S; Oliveira C; Taboada RG; Xerfan MP; Mauro CC; Silva VS; Barros M; de Jesus VHF; Felismino T; Aguiar S; Gobo ML; Mello CA; Riechelmann RP
Clin Colorectal Cancer; 2020 Sep; 19(3):e129-e136. PubMed ID: 32389596
[TBL] [Abstract][Full Text] [Related]
5. Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.
Place RJ; Gregorcyk SG; Huber PJ; Simmang CL
Dis Colon Rectum; 2001 Apr; 44(4):506-12. PubMed ID: 11330577
[TBL] [Abstract][Full Text] [Related]
6. Long-term effects of chemoradiotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of the HIV disease.
Fraunholz IB; Haberl A; Klauke S; Gute P; Rödel CM
Dis Colon Rectum; 2014 Apr; 57(4):423-31. PubMed ID: 24608297
[TBL] [Abstract][Full Text] [Related]
7. Anal Squamous Cell Carcinoma: Radiation Therapy Alone Must Be Avoided.
Almaazmi H; Taylor JP; Stem M; Yu D; Lo BD; Safar B; Efron JE
J Surg Res; 2020 Mar; 247():530-540. PubMed ID: 31648811
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prognostic factors after primary chemoradiotherapy of anal cancer: A multicenter study of the German Cancer Consortium-Radiation Oncology Group (DKTK-ROG).
Martin D; Schreckenbach T; Ziegler P; Filmann N; Kalinauskaite G; Tinhofer I; Budach V; Gani C; Zips D; Schimek-Jasch T; Schäfer H; Grosu AL; Thomas E; Krause M; Dapper H; Combs S; Hoffmann C; Stuschke M; Walter F; Belka C; Kurth I; Hadiwikarta WW; Baumann M; Rödel C; Fokas E
Radiother Oncol; 2022 Feb; 167():233-238. PubMed ID: 34999135
[TBL] [Abstract][Full Text] [Related]
9. HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era.
Grew D; Bitterman D; Leichman CG; Leichman L; Sanfilippo N; Moore HG; Du K
Dis Colon Rectum; 2015 Dec; 58(12):1130-6. PubMed ID: 26544809
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and Outcome of Routine Use of Concurrent Chemoradiation in HIV-positive Patients With Squamous Cell Anal Cancer.
Leiker AJ; Wang CJ; Sanford NN; Aguilera TA; Karri S; Beg MS; Kazmi SA; Olson C; Matthews JA; Abdelnaby A; Meyer JJ; Folkert MR
Am J Clin Oncol; 2020 Oct; 43(10):701-708. PubMed ID: 32694298
[TBL] [Abstract][Full Text] [Related]
11. Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals.
Cunin L; Alfa-Wali M; Turner J; Bower M; Ion L; Allen-Mersh T
Ann Surg Oncol; 2014 Feb; 21(2):527-32. PubMed ID: 24242676
[TBL] [Abstract][Full Text] [Related]
12. Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience.
Jethwa KR; Day CN; Sandhyavenu H; Gonuguntla K; Harmsen WS; Breen WG; Routman DM; Garda AE; Hubbard JM; Halfdanarson TR; Neben-Wittich MA; Merrell KW; Hallemeier CL; Haddock MG
Clin Transl Radiat Oncol; 2021 May; 28():17-23. PubMed ID: 33732911
[TBL] [Abstract][Full Text] [Related]
13. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
[No Abstract] [Full Text] [Related]
14. Chemoradiation-Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal Canal.
Lee G; Kim DW; Muralidhar V; Mitra D; Horick NK; Eyler CE; Hong TS; Drapek LC; Allen JN; Blaszkowsky LS; Giantonio B; Parikh AR; Ryan DP; Clark JW; Wo JY
Oncologist; 2020 Dec; 25(12):1015-1022. PubMed ID: 32827337
[TBL] [Abstract][Full Text] [Related]
15. Prognostic and Predictive Clinicopathologic Factors of Squamous Anal Canal Cancer in HIV-Positive and HIV-Negative Patients: Does HAART Influence Outcomes?
Pappou EP; Magruder JT; Fu T; Hicks CW; Herman JM; Fang S; Wick EC; Safar B; Gearhart SL; Efron JE
World J Surg; 2018 Mar; 42(3):876-883. PubMed ID: 28948325
[TBL] [Abstract][Full Text] [Related]
16. Improved Tumor Control Related to Radiotherapy Technological Development for Hypopharyngeal Cancer.
Susko MS; Lazar AA; Dhar S; Chan JW; Shiao SL; Chapman CH; Johnson J; Quivey JM; Ryan WR; Heaton CM; Ha PK; Yom SS
Laryngoscope; 2021 Feb; 131(2):E452-E458. PubMed ID: 32396214
[TBL] [Abstract][Full Text] [Related]
17. Are there HIV-specific Differences for Anal Cancer Patients Treated with Standard Chemoradiotherapy in the Era of Combined Antiretroviral Therapy?
Martin D; Balermpas P; Fokas E; Rödel C; Yildirim M
Clin Oncol (R Coll Radiol); 2017 Apr; 29(4):248-255. PubMed ID: 28049602
[TBL] [Abstract][Full Text] [Related]
18. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.
Oehler-Jänne C; Huguet F; Provencher S; Seifert B; Negretti L; Riener MO; Bonet M; Allal AS; Ciernik IF
J Clin Oncol; 2008 May; 26(15):2550-7. PubMed ID: 18427149
[TBL] [Abstract][Full Text] [Related]
19. Effect of CD4 Count on Treatment Toxicity and Tumor Recurrence in Human Immunodeficiency Virus-Positive Patients With Anal Cancer.
Bryant AK; Mudgway R; Huynh-Le MP; Simpson DR; Mell LK; Gupta S; Sharabi AB; Murphy JD
Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):478-485. PubMed ID: 29102276
[TBL] [Abstract][Full Text] [Related]
20. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
